Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

Clinical trial NCT06642506 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06642506
Sponsor: Ludwig-Maximilians - University of Munich
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Esophagus Adenocarcinoma Esophagus Cancer Metabolome Mass Spectrometry Precision Medicine Oncology Patients Receiving Chemotherapy Metabolomics Chemoresistance

Start date: 2024-10-06
Primary completion: 2025-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.